Stem-Cell Therapy Approved for Blood Disorders

Allocord is prepared from cord blood cells from multiple cord blood banks. Despite donor screening, recipients of the product are at risk for infection by adventitious agents as well as the transmission of leukemia and rare genetic diseases originating from the donor cells, according to the labeling.

http://www.ashp.org/menu/News/PharmacyNews/NewsArticle.aspx?Source=News&Type=Rss&Id=3908